Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v8-FR
Language English French
Date Updated 2019-12-21 2019-12-20
Drug Identification Number 02456176 02456176
Brand name BORTEZOMIB BORTEZOMIB
Common or Proper name BORTEZOMIB BORTEZOMIB
Company Name APOTEX INC APOTEX INC
Ingredients BORTEZOMIB BORTEZOMIB
Strength(s) 3.5MG 3.5MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS
Packaging size 3.5 VIAL 3.5 VIAL
ATC code L01XX L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-12-09 2019-12-09
Estimated end date 2020-01-06 2020-01-06
Actual end date 2019-12-20 2019-12-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments